Cargando…

Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease

Alcohol consumption is a global healthcare problem. Chronic alcohol consumption generates a wide spectrum of hepatic lesions, the most characteristic of which are steatosis, hepatitis, fibrosis, and cirrhosis. Alcoholic liver diseases (ALD) refer to liver damage and metabolomic changes caused by exc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyun, Ji Ye, Kim, Seul Ki, Yoon, Sang Jun, Lee, Su Been, Jeong, Jin-Ju, Gupta, Haripriya, Sharma, Satya Priya, Oh, Ki Kwong, Won, Sung-Min, Kwon, Goo Hyun, Cha, Min Gi, Kim, Dong Joon, Ganesan, Raja, Suk, Ki Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368757/ https://www.ncbi.nlm.nih.gov/pubmed/35955885 http://dx.doi.org/10.3390/ijms23158749

Ejemplares similares

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

The Link between Gut Microbiota and Hepatic Encephalopathy
por: Won, Sung-Min, et al.
Publicado: (2022)

Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Microbiome and metabolomics in alcoholic liver disease
por: Ganesan, Raja, et al.
Publicado: (2022)

The Lactobacillus as a Probiotic: Focusing on Liver Diseases
por: Jeong, Jin-Ju, et al.
Publicado: (2022)

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
por: Raja, Ganesan, et al.
Publicado: (2021)

Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver
por: Gupta, Haripriya, et al.
Publicado: (2021)

Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
por: Gupta, Haripriya, et al.
Publicado: (2022)

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
por: Won, Sung-Min, et al.
Publicado: (2021)

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
por: Park, Eunju, et al.
Publicado: (2021)

Microbiome and Metabolomics in Liver Cancer: Scientific Technology
por: Ganesan, Raja, et al.
Publicado: (2022)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease
por: Choi, Ye Rin, et al.
Publicado: (2021)

Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021)

Effect of Korean Red Ginseng on metabolic syndrome
por: Yoon, Sang Jun, et al.
Publicado: (2021)

Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Role of Gut Microbiota in Hepatocarcinogenesis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease
por: Yu, Jeong Seok, et al.
Publicado: (2021)

Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease
por: Ganesan, Raja, et al.
Publicado: (2022)

Diet-Regulating Microbiota and Host Immune System in Liver Disease
por: Eom, Jung A, et al.
Publicado: (2021)

Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma
por: Seok, Jun, et al.
Publicado: (2020)

The usefulness of the Korean version of modified Mini-Mental State Examination (K-mMMSE) for dementia screening in community dwelling elderly people
por: Jeong, Seul-Ki, et al.
Publicado: (2004)

In vitro fertilization outcomes in women with surgery induced diminished ovarian reserve after endometrioma operation: Comparison with diminished ovarian reserve without ovarian surgery
por: Hong, Su Been, et al.
Publicado: (2017)

Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats
por: Jeong, Jin-Ju, et al.
Publicado: (2023)

Prediction of Adverse Outcomes among Women in the Third Trimester of Pregnancy with Coronavirus Disease 2019
por: Kim, Hyun Mi, et al.
Publicado: (2022)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
por: Kim, Jimin, et al.
Publicado: (2021)

The impact of deep learning reconstruction in low dose computed tomography on the evaluation of interstitial lung disease
por: Kim, Chu hyun, et al.
Publicado: (2023)

Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
por: Kim, Seul Ki, et al.
Publicado: (2017)

Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
por: Jung, Jang Han, et al.
Publicado: (2022)

Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression
por: Kim, Seul-Ki, et al.
Publicado: (2019)

Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum
por: Lee, Na Young, et al.
Publicado: (2020)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
por: Kim, Ji Hyun, et al.
Publicado: (2020)

Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women
por: Kim, Haemin, et al.
Publicado: (2023)

The Role of the Gut Microbiome in Liver Cirrhosis Treatment
por: Lee, Na Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2sg60t9uuhojc619837u5fq28i